Drug · DIN 02171899
TIMOPTIC-XE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 2, 2020; first marketed December 31, 1995.
- Drug Identification Number (DIN)
- 02171899
- Company (DIN owner)
- Elvium Life SciencesToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution (Extended-Release)
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Timolol S01ED01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TIMOLOL (TIMOLOL MALEATE) | 0.5 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 20, 2020: NOC 24083New Drug Submission (NDS) · Administrative: Change in Product Ownership
- October 28, 2016: NOC 18658New Drug Submission (NDS) · Transfer of drug identification numbers
- June 17, 2005: NOC 7100New Drug Submission (NDS) · Manufacturer name change
- June 21, 1995: NOC 5273Supplement to a New Drug Submission (SNDS) · New dosage form: long acting gellan solution
Other DINs named TIMOPTIC-XE
- DIN 02171880 · Cancelled Post Market